Log In
Print this Print this

Andolast (CR2039)

  Manage Alerts
Collapse Summary General Information
Company Rottapharm Biotech s.r.l.
DescriptionAirway specific anti-inflammatory agent with calcium-activated potasssium channel properties
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today